If you run a 5 to 20 physician group and are not thinking about a sale, your billing setup probably feels like an ops problem — not a strategic one. That view costs practices real money when a deal process starts. As MSMS advisory guidance from April 2026 notes, billing gaps and charge capture issues have shaped more than 40% of provider-side M&A deals. This leads to lower valuations, re-negotiations, or deals that fall apart.
Physician practice M&A activity remained strong into 2026, with private equity firms completing 79 deals in Q1 alone – part of a broader wave of healthcare PE activity that drove over $191 billion in global deal value. Cardiology groups are trading at 8 to 11x EBITDA. Gastroenterology at 8 to 10x. Orthopedics & Sports Medicine at 7 to 10x. But the multiple your practice actually receives is not set by specialty benchmarks. It is set by what buyers find when they open your billing records.
What Buyers Are Actually Looking At
Buyers no longer take reported financials at face value. The current standard is normalized EBITDA built from audited billing data. Your buyer’s team will rebuild your revenue from claim-level records – not your P&L summary.
They look at four things. The first is your first-pass claim acceptance rate – whether claims clear on submission or enter a denial queue that delays your revenue. The second is your denial rate by payer and procedure – whether your billing team has a set process for resolving denials or handles them one by one.
The third is charge capture accuracy across your top CPT codes – whether what was billed matches what each encounter should have generated. The fourth is payer contract records – whether rates are current, contracts have been updated, and your team can show what you were owed versus what you were paid.
If your system cannot produce those four outputs on demand, you have a documentation gap. Buyers will not ask you to fix it. They will price it into your offer instead.
Small Billing Gaps, Large Valuation Impact.
The dollar amount is not the issue. The pattern is.
A $35 gap between what a claim should pay and what it actually pays seems small. But across 40,000 annual claims, that same $35 adds up to $1.4 million in lost revenue. When a buyer’s team spots that pattern in diligence, they do not fix it in your favor. They use it to justify a lower EBITDA – which means a lower offer.
This is what most practice owners miss. They see denial management as a billing problem. Buyers see it as a revenue reliability problem. Those two views lead to very different deal outcomes.
The Three RCM Findings That Kill Multiples
Undocumented payer contracts are a diligence risk. If your commercial rates are not tied to signed, current contracts, buyers will assume those rates could change. That adds uncertainty to their EBITDA model. And uncertainty gets priced as a discount.
High denial rates without a clear resolution process are a valuation risk. A 12% denial rate alone is not a deal-breaker. But no process to work those denials is a problem. It means your AR includes revenue that may never be collected. Buyers will haircut that AR in their model.
Another risk is Charge capture gaps on high-value procedures. Consistent undercoding on your top CPT codes does not show up as an error. It shows up as a lower revenue figure in a buyer’s model. Missed modifiers, incomplete notes, and skipped add-on codes all count. Buyers will model your revenue at the lower billed rate and will not adjust up for what you should have charged.
Each of these problems existed before you considered selling. The deal process just makes them expensive to ignore.
These three gaps are connected. Denial data should feed back into your charge capture workflow – when those steps run through separate systems. Fixing one does not fix the other. Diligence teams flag all three together. Buyers price the combined exposure.
Clean RCM Is Practice Valuation Infrastructure
The practices that command top-of-range multiples can produce claim-level audit trails without advance notice. Charge capture variance stays under 2%. Denial rates are low, stable, and tied to documented resolution workflows. Payer contract terms are on file and current. When a buyer’s team runs their normalization model, the numbers are traceable at the claim level.
That consistency does not come from a billing team working harder during diligence. Charge capture must close before denial tracking can begin, and denial data must feed back into documentation workflows – or the same coding gap recurs on the next claim. When those steps run through disconnected systems, your staff cannot produce a unified audit trail on demand. A buyer’s team working against a 30-day diligence window will not wait for your team to reconcile three tools. They will model the gap as revenue risk.
CERTIFY Pay links charge capture, denial tracking, and payer contract records in one place. Your billing and RCM operations run through one workflow. Denial patterns, charge rates, and contract terms all trace to the same log. You are not pulling records when a buyer asks. See how the full practice management system keeps your practice audit-ready
What to Do Before You Are in a Deal Process
You do not need to be actively selling to start here. These three steps protect your valuation whether a deal is two years out or five.
Run a 90-day claims audit. Pull first-pass acceptance rates, denial reason codes, and charge capture rates by CPT code. If denials cluster around certain procedures, payers, or documentation gaps, that is a workflow problem – not a staffing one. If you have not run this audit, a buyer’s diligence team will – and they will price what they find.
Document your payer contracts. Every commercial contract should be current, signed, and easy to find. If a contract has auto-renewed without a rate review, treat it as a diligence risk. Buyers will find it before you do.
Map your patient payment workflows. Buyers also review patient AR aging. When post-discharge collections run through a separate tool, your AR aging report shows balances your billing system cannot explain. A buyer’s normalization model will flag every one of them.
CERTIFY Pay’s patient payment tools move collection pre-visit and link each payment to your billing record. That way, the AR picture buyers see matches your actual collections.
The gap between a mid-range and a top-range multiple often comes down to one thing. Your billing records. Practices with similar EBITDA land different valuations based on whether their revenue cycle management software produces audit-ready output as a baseline.
A practice that produces clean audit output in 48 hours negotiates from a different position. One that needs three weeks to reconcile its own records negotiates from weakness. If you want to know where your practice stands, run a billing audit before a buyer does. Talk to CERTIFY Health team.
